Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+ T cell-mediated ferroptosis in castration-resistant prostate cancer
2021 · Acta Pharmaceutica Sinica B · 106 citations
https://doi.org/10.1016/j.apsb.2021.07.016